Search Clinical Trials
 
By Condition
 
By Location (USA)
 
By Location (Other)
 
By Sponsor
 
Resources
 
Privacy Policy
 
About Us
Disclaimer
Evaluation of the Causes and Disease Processes of Chronic Lung Disease Clinical Trials Data presented on Clinical Trials Search isn't meant to be a substitute for qualified health advice, calls or treatment using a genuine doctor. We are not docs. Always consult your dr. on Evaluation of the Causes and Disease Processes of Chronic Lung Disease conditions. Clinical Trials Search.org is a site dedicated to listing clinical research studies in human subjects. Evaluation of the Causes and Disease Processes of Chronic Lung Disease Clinical research trials and Evaluation of the Causes and Disease Processes of Chronic Lung Disease healthcare trials occur in a lot of of places throughout the United States. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials generally assess the potency of new drugs. The intent of the studies / undertakings is to figure out certain human medical questions. Clinical trials are a popular means for mDs, government agencies, and private sector corporations to locate remedies for all kinds of circumstances, including Evaluation of the Causes and Disease Processes of Chronic Lung Disease. Evaluation of the Causes and Disease Processes of Chronic Lung Disease Clinical Trials and other clinical trials allow volunteers to obtain health treatment alternatives before they are available to the masses. Many times the participants undergo treatment for free, and sometimes they are paid for their time. Occasionally there is a cost for a Evaluation of the Causes and Disease Processes of Chronic Lung Disease clinical trial. Participants typically obtain the most effective healthcare available for their Evaluation of the Causes and Disease Processes of Chronic Lung Disease condition. Dangers are a reality, nonetheless, and can include extra or frequent mD trips, medical hazards (potentially life-endangering), and/or the treatment being uneffective. Trials are federally regulated with rigid guidelines to protect clinical trials patients.

Home > "E" Clinical Trials Conditions > Evaluation of the Causes and Disease Processes of Chronic Lung Disease

Evaluation of the Causes and Disease Processes of Chronic Lung Disease



Evaluation of the Causes and Disease Processes of Chronic Lung Disease

For Condition: Lung Disease
Status: Recruiting
Sponsor(s): National Heart, Lung, and Blood Institute (NHLBI) ,
Synopsis: Chronic lung diseases are disorders associated with abnormalities in any of the structures involved in the process of breathing and bringing oxygen into the lungs and blood. This includes abnormalities in the airways, lungs, blood vessels in and around the lungs, and the tissue covering the lungs (pleura). The purpose of this research study is to evaluate patients referred to the Pulmonary-Critical Care Medicine Branch (P-CCMB) of the National Heart, Lung, and Blood Institute (NHLBI) in order to; 1. Develop a better understanding of the causes and disease processes involved in disorders of the lungs 2. Identify patients eligible to participate in other P-CCMB research studies
Details: The chronic lung diseases are those disorders associated with functional and/or structural derangement to the alveolar structures, airways, pulmonary blood vessels, pleura and/or mediastinum. The purpose of this project is to permit the comprehensive evaluation of patients referred to the Pulmonary-Critical Care Medicine Branch (P-CCMB) in order to: (1) develop an understanding of the etiology and pathogenesis of these disorders; and (2) identify individuals who will be suitable candidates for other P-CCMB protocols.
Eligibility:
Study Type:  Observational, Screening
Minimum Age/Maximum Age: /
Genders: Both
Protocol Entry Criteria: INCLUSION CRITERIA: Symptoms consistent with pulmonary disease. May have family history of lung disease. Patients with diseases of organs with know association with lung disease. EXCLUSION CRITERIA: Persons with no clinical evidence of lung disease.
Total Enrollment: 9999

Location and Contact Information:

National Heart, Lung and Blood Institute (NHLBI) *Recruiting*
Bethesda,  Maryland,  20892
United States
Recruiting Patient  and Public Liaison Office 1-800-411-1222


Additional Information:
Study ID Numbers:  820032;  82-H-0032
Study Start Date: March 11, 1982
Record last reviewed: February 9, 2004
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00001183

Other Lung Disease Studies:
1. Development of a Hospital-Based Home Program for the Use of Inhaled Nitric Oxide in the Chronic Management of Severe Cardiopulmonary Diseases

2. Evaluation of the Causes and Disease Processes of Chronic Lung Disease

3. An Open-Label Study of the Safety of Interferon gamma-1b in Patients with IPF

4. Natrecor in Pulmonary Hypertension

5. Benefits and Risks of Newborn Screening for Cystic Fibrosis

Related Studies:

Other Lung Disease Clinical Trials
Other Maryland Clinical Trials
Other Bethesda Clinical Trials

Evaluation of the Causes and Disease Processes of Chronic Lung Disease
Modify your Search

  Other Lung Disease Clinical Trials
  Other Maryland Clinical Trials
  Other Bethesda Clinical Trials


Warning: include(/var/www/cgi-bin/traxis/counter.php) [function.include]: failed to open stream: No such file or directory in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103

Warning: include() [function.include]: Failed opening '/var/www/cgi-bin/traxis/counter.php' for inclusion (include_path='.:/usr/local/lib/php') in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103